Rogisen News

04/19/04
NIH, Vision Loss from Eye Diseases Will Increase as Americans Age

With the aging of the population, the number of Americans with major eye diseases is increasing, and vision loss is becoming a major public health problem. By the year 2020, the number of people who are blind or have low vision is projected to increase substantially.

02/13/04
Berkeley Premium Nutraceuticals Launches Rogisen™
for Improving Night Vision

Berkeley Premium Nutraceuticals, the country’s leading developer of quality nutraceuticals, today announced the launch of Rogisen™, the once-daily, non-prescription dietary supplement to support improved night vision and ocular health.

01/27/04
Major Cincinnati Healthcare Company Consolidates Brands To Form Berkeley Premium Nutraceuticals

The companies producing the premium nutraceuticals Avlimil, Enzyte and Ogöplex, and the soon-to-be launched Altovis, Rogisen and Rovicid, have merged to form Berkeley Premium Nutraceuticals, Inc. The move consolidates Warner Health Care, Inc.; Wagner Nutraceuticals, Inc.; LifeKey, Inc.; and Boland Naturals, Inc., which will be maintained as subsidiaries of Berkeley.

These statements have not been reviewed by the Food and Drug Administration, and individual results may vary. Individuals shown are paid models and not necessarily Rogisen users. Rogisen should be taken as part of a healthy lifestyle and is not intended to treat or cure any disease.

For telephone orders, please call 1-800-965-3989

“I can’t imagine life without my vision. My sister was diagnosed with macular degeneration last year and it really got me thinking—how could I live without seeing the world? I take Rogisen, because I believe it is one proactive step I can take to protect what’s important to me.”